biotech

biotech

FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment

biotech

CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases

biotech

Researchers develop more reliable platform to test antibody medicines

biotech

Positive topline results from acne study

biotech

Sarbecovirus vaccine trial starts

biotech

Vetter Pharma to build new manufacturing site in Germany

biotech

New dementia treatment strategy proposed

biotech

FDA IND clearance for Trace Biosciences’ nerve-specific imaging agent